Trial
NCT00912509
Cross Linking for Treatment of Corneal Infection
UnknownTERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Price Vision Group
Collaborators
Cornea Research Foundation of America
Condition
Infectious Keratitis
Intervention
riboflavin
Why stopped
insufficient efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-22